These observations emphasize the importance of treatments that block the AngII-induced inflammatory process in human renal diseases and provide a rationale to investigate further the involvement of the AT2/NF-κB pathway in the inflammatory response in kidney diseases [20]. The gene discussed is NFKB1; the disease is kidney disorder.